Hong Chen
Physician Assistant · Brooklyn, NYNPI 1689921934
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Gilead at 39.5% of the total. Among physician assistant clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 871 payments — averaging $64.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$22K
- Phathom Pharmaceuticals, Inc.$11K
- IBSA Pharma Inc.$5K
- AbbVie$3K
- Amgen$3K
- Esperion Therapeutics, Inc.$2K
- plus $11K from 19 others
What the payments were for
- Consulting fees$3,5256%
- Speaking & faculty fees$23,74042%
- Travel & lodging$5,70410%
- Food & beverage$23,51642%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 152 | $22,331 |
| Phathom Pharmaceuticals, Inc. | 38 | $10,826 |
| IBSA Pharma Inc. | 38 | $4,701 |
| AbbVie | 95 | $2,851 |
| Amgen(2 entities) | 87 | $2,645 |
| Esperion Therapeutics, Inc. | 68 | $2,321 |
| Biohaven Pharmaceuticals, Inc. | 21 | $2,084 |
| Boehringer Ingelheim | 54 | $1,503 |
| AstraZeneca | 43 | $1,258 |
| Novo Nordisk | 32 | $1,002 |
| GSK | 39 | $989 |
| Biohaven Pharmaceutical Holding Company Ltd. | 27 | $804 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 52 | $727 |
| Amarin Pharma, Inc. | 27 | $576 |
| Pfizer | 21 | $387 |
| Aimmune Therapeutics, Inc. | 21 | $342 |
| Bayer | 13 | $260 |
| Lilly USA, LLC | 10 | $252 |
| Nestle Healthcare Nutrition Inc. | 10 | $162 |
| Novartis | 7 | $161 |
| Ironwood Pharmaceuticals, Inc | 5 | $113 |
| Sumitomo Pharma America, Inc. | 4 | $80 |
| Corcept Therapeutics | 3 | $67 |
| Biogen | 3 | $53 |
| Ipsen Biopharmaceuticals, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$56,511 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Epolamine | 1,019 | $937,575 |
| Diclofenac Potassium | 225 | $451,574 |
| VascepaIcosapent Ethyl | 819 | $404,962 |
| VemlidyTenofovir Alafenamide | 173 | $254,304 |
| JanuviaSitagliptin Phosphate | 163 | $148,884 |
| RybelsusSemaglutide | 109 | $148,489 |
| FarxigaDapagliflozin Propanediol | 161 | $146,003 |
| ZenpepLipase/Protease/Amylase | 57 | $137,072 |
| RestasisCyclosporine | 117 | $116,861 |
| OtezlaApremilast | 18 | $88,999 |
| ProliaDenosumab | 50 | $87,781 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 46 | $75,871 |
| KerendiaFinerenone | 88 | $74,606 |
| Dexlansoprazole DrDexlansoprazole | 293 | $72,034 |
| JardianceEmpagliflozin | 73 | $68,737 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Linzess, Creon, Qulipta, Ubrelvy | $2,851 | $288,510282 claims |
| GileadVemlidy | $22,331 | $254,304173 claims |
| AstraZenecaFarxiga, Nexium, Breztri Aerosphere | $1,258 | $221,422316 claims |
| AmgenOtezla, Prolia | $2,645 | $176,78068 claims |
| Novo NordiskRybelsus | $1,002 | $148,489109 claims |
| Aimmune Therapeutics, Inc.Zenpep | $342 | $137,07257 claims |
| Boehringer IngelheimJardiance, Tradjenta | $1,503 | $85,34393 claims |
| BayerKerendia | $260 | $74,60688 claims |
| Esperion Therapeutics, Inc.Nexletol, Nexlizet | $2,321 | $59,414100 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $727 | $38,67653 claims |
| IBSA Pharma Inc.Licart | $4,701 | $35,21742 claims |
| PfizerEliquis | $387 | $28,37027 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in Brooklyn
- Kaitlyn NelsonBrooklyn$289K
- Melissa VelezBrooklyn$68K
- Steven KongBrooklyn$66K
- Lindsey AxtBrooklyn$52K
- Gregory CelestinBrooklyn$41K
- Henry YuBronx$1M
- Michael AsbachAmherst$962K
- Janelle BunceJamestown$565K
- Kristyl Cuenca-SiskoNew York$478K
- Melissa WhiteGarden City$320K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.